We are live on
!
Find out more
RCMNY
Rubric Capital Management (New York) Portfolio holdings
AUM
$9.44B
1-Year Est. Return
68.42%
This Fund
S&P 500
This Quarter
Est. Return
+10.67%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
–
AUM
$291M
AUM Growth
–
Cap. Flow
+$281M
Cap. Flow
% of AUM
96.55%
Top 10 Holdings %
Top 10 Hldgs %
64.23%
Holding
37
New
37
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ironwood Pharmaceuticals
IRWD
|
+$19.2M |
| 2 |
NSM
Nationstar Mortgage Holdings
NSM
|
+$16.1M |
| 3 |
Adeia
ADEA
|
+$16M |
| 4 |
Olin
OLN
|
+$16M |
| 5 |
Signet Jewelers
SIG
|
+$12.5M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.72% |
| 2 | Healthcare | 11.17% |
| 3 | Materials | 9.53% |
| 4 | Financials | 6.84% |
| 5 | Consumer Discretionary | 5.3% |
Similar funds
SCM
RCM
SIM
NPT
AC
PVI
WPL
BAMF
Rubric Capital Management (New York)'s Q4 2016 Portfolio in Review
Q4 2016 is the first quarter with a 13F filing on record for Rubric Capital Management (New York), which disclosed 37 positions worth $291M. Its ten largest holdings account for 64% of the portfolio.
Its largest position is Ironwood Pharmaceuticals: 1,522,350 shares worth $19.5M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, followed by Healthcare and Materials.
- Rubric Capital Management (New York)'s largest Q4 2016 buy was Ironwood Pharmaceuticals: 1,522,350 shares worth $19.5M.
- Rubric Capital Management (New York)'s ten largest holdings make up 64% of its $291M portfolio in Q4 2016.
- Rubric Capital Management (New York) disclosed 37 positions in Q4 2016, its first 13F filing on record.
Based on Rubric Capital Management (New York)'s 13F filing for Q4 2016, filed 3 Feb 2017.